About Avadel Pharmaceuticals Plc

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

At the moment the company generates 69M USD in revenues.

On its last earning announcement, the company reported a loss of -2.52$ per share.

The book value per share is -0.72$

Avadel Pharmaceuticals Plc website


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
69M 79.70% -24M -34.79% -94M -2.52 - - 37M -0.72 -55M - -55M